Crozet, VA, United States of America

Kimberly A Kelly

This inventor holds 11 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of Virginia Patent Foundation, The General Hospital Corporation, Zielbio, Inc.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly A Kelly. Retrieved from https://idiyas.com/inventor/kimberly-a-kelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 90.9


 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Crozet, VA (US) (2014 - 2024)
  • Goochland, VA (US) (2021 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kimberly A. Kelly

Introduction

Kimberly A. Kelly is a prominent inventor based in Crozet, Virginia, known for her significant contributions to the field of biomedical research. With a total of 11 patents to her name, she has made remarkable strides in understanding and treating various cancers through innovative approaches.

Latest Patents

Among her latest patents is "Hornerin: a novel non-VEGF mediated angiogenic protein expressed in both human and mouse angiogenic endothelial cells and human pancreatic cancer cells." This patent provides compositions and methods for the use of hornerin-binding molecules, including peptides and antibodies. The disclosed subject matter includes methods for treating tumors, increasing survival rates in subjects with tumors, suppressing tumor growth, and reducing tumor vascularity. Additionally, it outlines methods for imaging cells and delivering active agents to cells that express hornerin. Another notable patent is "Plectin-1 binding antibodies and uses thereof," which offers compositions and methods for treating cancer characterized by surface expression of plectin-1. This patent discusses combinations of therapeutic agents that work synergistically to inhibit cancer cell growth.

Career Highlights

Kimberly has worked with esteemed institutions such as the University of Virginia and The General Hospital Corporation. Her work has significantly impacted cancer research and treatment methodologies, showcasing her dedication to advancing medical science.

Collaborations

Throughout her career, Kimberly has collaborated with notable professionals in her field, including Ralph Weissleder and Nabeel Bardeesy. These collaborations have further enriched her research and contributed to her innovative patents.

Conclusion

Kimberly A. Kelly's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the biomedical field. Her work continues to inspire advancements in treatment methodologies and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…